A brain neoplasm is a neoplasm (tumor) that occurs in the brain due to an abnormal growth or division of cells, or neoplasia. Neoplasms can be benign, pre-malignant, or malignant, in which case the patient is considered to have cancer. Causes of brain tumors are typically unknown, but some are related to an exposure to radiation or an inherited mutation on the TAG gene. Tumors that start in the brain are called primary, while those that start elsewhere in the body and migrate to the brain are of development. Possible treatments of brain neoplasms include surgery, radiation therapy, and chemotherapy.
Brain Neoplasms Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Brain Neoplasms below!
For more information on how to use Laverne, please read the How to Guide.
We have 3608 products for the study of Brain Neoplasms that can be applied to Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Brain Neoplasms is also known as Brain Neoplasm, Brain Tumor, Brain Tumors, Brain Tumour, Neoplasm Of Brain.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.